By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Hims & Hers leverages ZAVA's expertise to enter Europe's weight-loss market, boosting growth and profitability. Read what ...

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...

Hims & Hers (NYSE: HIMS) stock, a prominent player in the booming telehealth sector, has undeniably captured significant investor attention recently. Perhaps you, like many others, have been caught up ...

Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its way into Europe and wants to build more personalized drugs for its ...

While most high schoolers spend their summer vacation hanging out with friends, Genesis Lewis is spending hers gearing up for an international golf competition. The North Carolina rising senior will ...

As of early June, HIMS stock is hovering around $55 per share, representing a roughly 33% decline from its all-time high reached in early 2025. Indeed, Hims & Hers has subjected investors to a ...

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $55.25, denoting a -2.83% change from the preceding trading day.

Hims & Hers has been expanding its presence in the weight management market, with its existing Novo partnership representing ...